Citation: Ho. Leven et Eo. Kehinde, PERCUTANEOUS MANAGEMENT OF A CHRONIC POSTTRANSPLANT URETERAL LEAK - REPORT OF A CASE, Scandinavian journal of urology and nephrology, 31(1), 1997, pp. 99-101
Authors:
KEHINDE EO
WHEATLEY T
FEEHALLY J
NICHOLSON ML
VEITCH PS
BELL PRF
Citation: Eo. Kehinde et al., IMMUNOSUPPRESSION FOR RECIPIENTS OF KIDNEYS FROM NON-HEART-BEATING DONORS - COMPARISON OF TRIPLE THERAPY AND OKT3 REGIMENS, Transplantation proceedings, 28(3), 1996, pp. 1338-1339
Authors:
KEHINDE EO
FEEHALLY J
SCRIVEN SD
VEITCH PS
BELL PRF
Citation: Eo. Kehinde et al., TREATMENT OF STEROID-RESISTANT REJECTION FOLLOWING RENAL-TRANSPLANTATION - BENEFITS AND RISKS OF OKT3 THERAPY, Transplantation proceedings, 28(3), 1996, pp. 1449-1450
Authors:
VARTY K
VEITCH PS
MORGAN JDT
KEHINDE EO
DONNELLY PK
BELL PRF
Citation: K. Varty et al., RESPONSE TO ORGAN SHORTAGE - KIDNEY RETRIEVAL PROGRAM USING NON-HEART-BEATING DONORS, BMJ. British medical journal, 308(6928), 1994, pp. 575-575
Authors:
KEHINDE EO
VEITCH PS
SCRIVEN SD
VARTY K
MORGAN JDT
FURNESS P
HORSBURGH T
FEEHALLY J
BELL PRF
Citation: Eo. Kehinde et al., COMPLICATIONS OF USING OKT3 FOR INDUCTION OF IMMUNOSUPPRESSION IN RECIPIENTS OF KIDNEYS FROM NONHEART BEATING DONORS, Transplantation proceedings, 26(6), 1994, pp. 3123-3125
Authors:
KEHINDE EO
SCRIVEN SD
FEEHALLY J
VEITCH PS
VARTY K
BELL PRF
Citation: Eo. Kehinde et al., ADVERSE-EFFECTS OF OKT3 THERAPY - INCREASED RISK WITH IMPAIRED RENAL-FUNCTION, Transplantation proceedings, 26(4), 1994, pp. 1945-1947
Authors:
KEHINDE EO
PETERMANN A
MORGAN JD
BUTT ZA
DONNELLY PK
VEITCH PS
BELL PRF
Citation: Eo. Kehinde et al., TRIPLE THERAPY AND INCIDENCE OF DE-NOVO CANCER IN RENAL-TRANSPLANT RECIPIENTS, British Journal of Surgery, 81(7), 1994, pp. 985-986
Authors:
KEHINDE EO
DONNELLY PK
COOKSEY G
TERRY TR
Citation: Eo. Kehinde et al., SAVE THE APPENDIX - A USEFUL CONDUIT FOR RECONSTRUCTIVE SURGERY, The European journal of surgery, 159(9), 1993, pp. 509-511